Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Beta Drugs Ltd.

Dec 12 NSE 1642.90(+ 23.40 1.44%)

Volume1514

Prev. Close
1619.50

Open Price
1627.60

Today's Low / High

1622.40 1650.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

1428.95 2170.46

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	362.36	295.71	227.11	183.84	116.12
Total Operating Revenues	362.36	295.71	227.11	183.84	116.12

Other Income	6.44	1.36	0.75	0.76	0.50
Total Revenue	368.79	297.07	227.87	184.59	116.62

EXPENSES
Cost Of Materials Consumed	175.78	167.65	110.40	96.21	60.55
Operating And Direct Expenses	40.62	31.79	24.29	17.78	13.40
Changes In Inventories Of FG,WIP And Stock-In Trade	-4.42	-18.24	-4.71	-1.75	-1.77
Employee Benefit Expenses	33.92	25.89	22.70	15.91	10.88
Finance Costs	6.99	2.82	2.41	1.90	2.42
Depreciation And Amortisation Expenses	12.51	9.78	10.41	7.25	6.87
Other Expenses	41.86	28.63	21.31	12.99	8.31
Total Expenses	307.25	248.32	186.81	150.29	100.67

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	61.54	48.75	41.06	34.30	15.95

Exceptional Items	-4.57	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	56.97	48.75	41.06	34.30	15.95

Tax Expenses-Continued Operations
Current Tax	14.97	12.53	10.86	9.51	4.71
Deferred Tax	-0.42	-0.21	-0.52	-0.03	-0.48
Total Tax Expenses	14.55	12.32	10.34	9.47	4.23
Profit/Loss After Tax And Before ExtraOrdinary Items	42.42	36.44	30.72	24.83	11.72

Profit/Loss From Continuing Operations	42.42	36.44	30.72	24.83	11.72

Profit/Loss For The Period	42.42	36.44	30.72	24.83	11.72
Consolidated Profit/Loss After MI And Associates	42.42	36.44	30.72	24.83	11.72

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	42.02	37.90	31.95	25.82	12.20
Diluted EPS (Rs.)	42.02	37.90	31.95	25.82	12.20

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	362.36
Total Operating Revenues	362.36
Other Income	6.44
Total Revenue	368.79
EXPENSES
Cost Of Materials Consumed	175.78
Operating And Direct Expenses	40.62
Changes In Inventories Of FG,WIP And Stock-In Trade	-4.42
Employee Benefit Expenses	33.92
Finance Costs	6.99
Depreciation And Amortisation Expenses	12.51
Other Expenses	41.86
Total Expenses	307.25
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	61.54
Exceptional Items	-4.57
Profit/Loss Before Tax	56.97
Tax Expenses-Continued Operations
Current Tax	14.97
Deferred Tax	-0.42
Total Tax Expenses	14.55
Profit/Loss After Tax And Before ExtraOrdinary Items	42.42
Profit/Loss From Continuing Operations	42.42
Profit/Loss For The Period	42.42
Consolidated Profit/Loss After MI And Associates	42.42
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	42.02
Diluted EPS (Rs.)	42.02